L&K Biomed Co Ltd (156100)

KOSDAQ

Currency in KRW

7,320

-50(-0.68%)

Closed·14/08

Fair Value

Unlock Value

Day's Range

7,290

7,530

52 wk Range

5,570

8,580

156100 Financial Summary

A brief financial summary of L&K Biomed Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio23.06

Price/Book2.67

Debt / Equity64.83%

Return on Equity19.41%

Dividend Yield0.00%

EBITDA5.65B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

19,356.05

15,372.57

19,767.46

29,904.81

36,092.22

Gross Profit

aa.aa

13,456.7

7,353.63

14,792.03

25,677.83

30,142.25

Operating Income

aa.aa

-3,858.78

-15,280.38

-12,738.4

2,034.1

3,077.76

Net Income

aa.aa

-10,715.06

-9,668.52

-13,625.17

-1,867.3

9,743.25

Balance Sheet

Total Assets

aa.aa

58,995.41

59,285.46

52,663.33

62,762.24

83,061.02

Total Current Liabilities

aa.aa

19,663.96

12,612.57

37,980.73

22,763.22

39,074.09

Total Equity

aa.aa

34,163.24

24,786.89

10,761.72

30,586.92

36,033

Cash Flow

Levered Free Cash Flow

aa.aa

6,775.64

619.25

-252.54

-9,868.58

-4,469.4

Cash from Operations

aa.aa

-776.7

-10,599.83

-6,881.02

-1,369.94

-7,430.18

Cash from Investing

aa.aa

-1,297.24

5,300.86

-2,501.51

-6,413.46

-9,001.18

Cash from Financing

aa.aa

178.21

16,353.21

732.72

5,629.09

17,569.5

Net Change in Cash

aa.aa

4,207.47

11,197.48

-8,712.74

-2,347.82

-1,212.18

* In Millions of KRW (except for per share items)

Earnings

Latest Release

May 15, 2025

EPS / Forecast

-30.37 / --

Revenue / Forecast

8.89B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were L&K Biomed's earnings for the latest quarter?

The L&K Biomed EPS (TTM) is 279.78. L&K Biomed reported sales of 8,893.17, net income of -605.41, and EPS of -30.37 for the latest quarter.

What was L&K Biomed's net income for the latest quarter?

L&K Biomed's net income for the latest quarter was -605.41.

How did L&K Biomed's performance compare year-over-year in the latest quarter?

The company's revenue moved from 10,024.11 in the previous quarter to 8,893.17 in the latest quarter, and net income moved from 6,316.67 to -605.41 compared to the previous quarter.

What is L&K Biomed's net profit margin on a TTM basis?

L&K Biomed's trailing twelve months (TTM) net profit margin is 27.00%.

How does L&K Biomed's debt to equity ratio compare to industry standards?

L&K Biomed's total debt-to-equity ratio is 64.83%.

What is L&K Biomed's return on investment on a TTM basis?

L&K Biomed's trailing twelve months (TTM) return on investment (ROI) is 19.41%.

Did L&K Biomed gain or lose cash last quarter?

In the latest quarter, L&K Biomed's net change in cash was 502.17 million.

What were L&K Biomed's total assets and liabilities in the latest quarter?

As of the latest quarter, L&K Biomed reported total assets of 85,330.43 million and total liabilities of 39,802.34 million.

How has L&K Biomed's total revenue grown this year?

L&K Biomed's total revenue was 10,024.11 in the previous quarter and 8,893.17 in the latest quarter.

What is L&K Biomed's gross margin on a TTM basis?

L&K Biomed's trailing twelve months (TTM) gross margin is 82.21%.

What was L&K Biomed's revenue per share for the latest quarter?

L&K Biomed's revenue per share for the latest quarter was 2,981.14.

NSE 30

5,282.27

-20.65

-0.39%

NSE All Share

144,628.20

-738.83

-0.51%

US 30

44,974.80

+63.5

+0.14%

US 500

6,455.80

-12.7

-0.20%

FTSE 100

9,142.25

-34.99

-0.38%

DAX

24,384.30

+17.48

+0.07%

South Africa Top 40

94,440.31

-125.88

-0.13%

Market Movers

Name	Last	Chg. %	Vol.
Aiico	3.80	-9.31%	117.39M
Ellah Lakes	14.88	-6.42%	34.24M
First HoldCo	32.85	0.00%	23.96M
Guaranty Trust Holding	97.70	+0.51%	20.67M
UBA	48.00	-0.62%	13.99M
Zenith Bank	72.40	+0.56%	13.81M
Lafarge Africa	138.00	0.00%	5.07M

Name	Last	Chg. %	Vol.
Mutual Benefits Assurance	3.85	+10.00%	102.42M
Ikeja	22.650	+9.95%	4.00M
Wema Bank	22.75	+9.90%	2.11M
Deap Capital Management Trust	1.61	+9.52%	4.69M
Tripple Gee and Co	5.60	+8.32%	483.48K
Dangote Sugar	55.95	+6.57%	3.19M
Fidson	43.900	+5.91%	805.81K

Name	Last	Chg. %	Vol.
Linkassure	2.43	-10.00%	50.01M
International Energy Insurance	3.33	-10.00%	4.58M
Lasaco Assurance PLC	4.05	-10.00%	52.85M
Nem	32.500	-9.97%	607.38K
Meyer	16.75	-9.95%	300.54K
Regal Insurance	1.36	-9.93%	46.96M
Coronation Insurance	3.63	-9.93%	28.60M

Trending Stocks

Name	Last	Chg. %	Vol.
Ellah Lakes	14.88	-6.42%	34.24M
Aiico	3.80	-9.31%	117.39M
Access Holdings	27.95	+1.08%	10.81M
VFD PLC	11.90	+0.85%	3.66M
Wema Bank	22.75	+9.90%	2.11M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aaaaaaaa Aa Aa	5,379.30	+47.74%	7,947.38
Aaaaaaaaaaaaaaaaa	577.00	+42.85%	824.24
Aaaaa Aaa Aaaa Aa	1,890.00	+37.82%	2,604.80
A Aaaaaaa Aaa A	71.00	+26.42%	89.76
Aaa Aa	168.60	+26.21%	212.79
Aaa Aaaaaaa	640.00	+16.53%	745.79

Name	Last	Upside	Fair Value
Aaaa Aaaaaaaa Aa Aa	5,379.30	+47.74%	7,947.38
Aaaaaaaaaaaaaaaaa	577.00	+42.85%	824.24
Aaaaa Aaa Aaaa Aa	1,890.00	+37.82%	2,604.80
A Aaaaaaa Aaa A	71.00	+26.42%	89.76
Aaa Aa	168.60	+26.21%	212.79
Aaa Aaaaaaa	640.00	+16.53%	745.79

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

L&K Biomed Co Ltd (156100)

156100 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were L&K Biomed's earnings for the latest quarter?

What was L&K Biomed's net income for the latest quarter?

How did L&K Biomed's performance compare year-over-year in the latest quarter?

What is L&K Biomed's net profit margin on a TTM basis?

How does L&K Biomed's debt to equity ratio compare to industry standards?

What is L&K Biomed's return on investment on a TTM basis?

Did L&K Biomed gain or lose cash last quarter?

What were L&K Biomed's total assets and liabilities in the latest quarter?

How has L&K Biomed's total revenue grown this year?

What is L&K Biomed's gross margin on a TTM basis?

What was L&K Biomed's revenue per share for the latest quarter?

Trending Stocks